Br J Psychiatry 2001; 178:145-153 8. Ashton H. Guidelines for the rational use of benzodiazepines: when and what to use. Drugs 1994; 48:25-40 9. Astrom M. Generalized anxiety disorder in stroke patients. A 3-year longitudinal study. Stroke 1996; 27 (2) :270-5. 10. Ballenger JC. Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder. J Clin Psychiatry 2001; 62 (suppl 19) :11-19 11. Ballenger JC, Davidson JRT, Lecrubier Y, et al. Consensus statement on depression, anxiety and functional gastrointestinal disorders. J Clin Psychiatry 2001, 62 (suppl. 8): 48-51. 12. Ballenger JC, Davidson JRT, Lecrubier Y, et al. Consensus statement on generalized anxiety disorder from the International Consensus group on Depression and anxiety. J Clin Psychiatry 2001, 62 (suppl. 11): 53-58 13. Bittner A, Goodwin RD, Wittchen HU, et al. What characteristics of primary anxiety disorders predict subsequent major depressive disorder? J Clin Psychiatry. 2004 May; 65 (5) :618-26 14. Brawman-Mintzer O. Pharmacologic treatment of generalized anxiety disorder. Psychiatr Clin North Am 2001, 24:119-137 15. Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact and treatment. Psychosomatic Medicine, 2003; 65: 963-970. 16. Castillo CS, Schultz SK, Robinson RG. Clinical correlates of early-onset and late-onset poststroke generalized anxiety. Am J Psychiatry. 1995 Aug; 152 (8) :1174-9. 17. Colman SS, Brod M, Potter LP, et al. Cross-sectional 7-year follow-up of anxiety in primary care patients. Depression and Anxiety 2004; 19:105-111. 18. Cottraux J. Recent developments in the research on generalized anxiety disorder. Curr Opin Psychiatry 2004; 17:49-52. 19. Culpepper L. Generalized anxiety disorder in primary care: emerging issues in management and treatment. J Clin Psychiatry 2002, 63 (suppl. 8): 35-41 20. Curtis BM, O'Keefe JH. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc 2002; 77:45-54. 21. Davidson JRT. Pharmacotherapy of generalized anxiety disorder. J Clin Psychiatry 2001, 62 (suppl. 11): 46-50. 22. Davidson JRT, DuPont RL, Hedges D, et al. Efficacy, safety and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J Clin Psychiatry 1999; 60: 528-535. 23. Didden DG, Philbrick JT, Schorling JB. Anxiety and depression in an internal medicine resident continuity clinic: difficult diagnoses. Int J Psychiatry Med. 2001, 31 (2) :155-67 24. Dugas MJ, Gagnon F, Ladouceur R. et al. Generalized anxiety disorder: a preliminary test of a conceptual model. Behav Res Ther, 1998; 36:215-226. 25. Fava M, Rankin MA, Wright EC, et al. Anxiety disorders in major depression. Compr Psychiatry 2000, 41:97-102. 26. Fifer SK, Mathias SD, Patrick DL., Et al. Untreated anxiety among adult primary care patients in a Health Maintenance Organization. Arch Gen Psychiatry 1994; 51: 740-750. 27. Franco-Bronson K. The management of treatment-resistant depression in the medically ill.
No comments:
Post a Comment